COMPLETE TEST BANK:
For Pharmacology: A Patient-Centered Nursing Process Approach 12th Edition
By Linda E. Mccuistion Phd
Questions And Answers GRADED
A+
,TABLE OF CONTENTS
CHAPTER 01: DRUG DEVELOPMENT AND ETHICAL CONSIDERATIONS..................................................4
CHAPTER 02: PHARMACOKINETICS, PHARMACODYNAMICS, ANDPHARMACOGENETICS ................ 11
CHAPTER 03: CULTURAL CONSIDERATIONS ..................................................................................... 18
CHAPTER 04: COMPLEMENTARY AND ALTERNATIVE THERAPIES ....................................................... 21
CHAPTER 05: PEDIATRIC CONSIDERATIONS. ................................................................................... 26
CHAPTER 06: GERIATRIC CONSIDERATIONS ..................................................................................... 31
CHAPTER 07: DRUGS IN SUBSTANCE USE DISORDER ........................................................................36
CHAPTER 08: THE NURSING PROCESS AND PATIENT-CENTERED CARE ............................................... 45
CHAPTER 09: SAFETY AND QUALITY ................................................................................................. 49
CHAPTER 10: DRUG ADMINISTRATION ............................................................................................. 54
CHAPTER 11: DRUG CALCULATIONS ................................................................................................ 58
CHAPTER 12: FLUID VOLUME AND ELECTROLYTES............................................................................ 63
CHAPTER 13: VITAMIN AND MINERAL REPLACEMENT........................................................................ 70
CHAPTER 14: NUTRITIONAL SUPPORT ............................................................................................. 76
CHAPTER 15: ADRENERGIC AGONISTS AND ANTAGONISTS ..............................................................83
CHAPTER 16: CHOLINERGIC AGONISTS AND ANTAGONISTS ............................................................. 89
CHAPTER 17: STIMULANTS .............................................................................................................. 94
CHAPTER 18: DEPRESSANTS ........................................................................................................... 98
CHAPTER 19: ANTISEIZURE DRUGS ................................................................................................103
CHAPTER 20: DRUGS FOR PARKINSONISM AND ALZHEIMER'S DISEASE ......................................... 109
CHAPTER 21: DRUGS FOR NEUROMUSCULAR DISORDERS AND MUSCLESPASMS ........................... 114
CHAPTER 22: ANTIPSYCHOTICS AND ANXIOLYTICS ........................................................................ 120
,CHAPTER 23: ANTIDEPRESSANTS AND MOOD STABILIZERS........................................................... 126
CHAPTER 24: ANTIINFLAMMATORIES ............................................................................................ 132
CHAPTER 25: ANALGESICS ............................................................................................................ 144
CHAPTER 26: ANTIBACTERIALS .......................................................................................................150
CHAPTER 27: ANTITUBERCULARS, ANTIFUNGALS, AND ANTIVIRALS ................................................159
CHAPTER 28: PEPTIDES, ANTIMALARIALS, AND ANTHELMINTICS .................................................... 165
CHAPTER 29: HIV- AND AIDS-RELATED DRUGS ............................................................................... 175
CHAPTER 30: TRANSPLANT DRUGS ................................................................................................ 179
CHAPTER 31: VACCINES ................................................................................................................ 182
CHAPTER 32: ANTICANCER DRUGS................................................................................................ 186
CHAPTER 33: TARGETED THERAPIES TO TREAT CANCER.................................................................... 190
CHAPTER 34: BIOLOGIC RESPONSE MODIFIERS .............................................................................. 192
CHAPTER 35: UPPER RESPIRATORY DISORDERS .............................................................................. 196
CHAPTER 36: LOWER RESPIRATORY DISORDERS.............................................................................. 200
CHAPTER 37: CARDIAC GLYCOSIDES, ANTIANGINALS, ANDANTIDYSRHYTHMICS ............................ 204
CHAPTER 38: DIURETICS ................................................................................................................211
CHAPTER 39: ANTIHYPERTENSIVES................................................................................................ 214
CHAPTER 40: ANTICOAGULANTS, ANTIPLATELETS, AND THROMBOLYTICS ....................................... 220
CHAPTER 41: ANTIHYPERLIPIDEMICS AND PERIPHERAL VASODILATORS ......................................... 225
CHAPTER 42: GASTROINTESTINAL TRACT DISORDERS .................................................................... 229
CHAPTER 43: ANTIULCER DRUGS .................................................................................................. 240
CHAPTER 44: EYE AND EAR DISORDERS ......................................................................................... 245
CHAPTER 45: DERMATOLOGIC DISORDERS .................................................................................... 248
CHAPTER 46: PITUITARY, THYROID, PARATHYROID, AND ADRENALDISORDERS ................................ 252
CHAPTER 47: ANTIDIABETICS......................................................................................................... 258
CHAPTER 48: URINARY DISORDERS ................................................................................................264
CHAPTER 49: PREGNANCY AND PRETERM LABOR........................................................................... 268
CHAPTER 50: LABOR, DELIVERY, AND POSTPARTUM ....................................................................... 273
CHAPTER 51: NEONATAL AND NEWBORN ...................................................................................... 276
, CHAPTER 52: WOMEN'S REPRODUCTIVE HEALTH ............................................................................280
CHAPTER 53: MEN'S REPRODUCTIVE HEALTH................................................................................. 283
CHAPTER 54: SEXUALLY TRANSMITTED INFECTIONS....................................................................... 286
CHAPTER 55: ADULT AND PEDIATRIC EMERGENCY DRUGS. ...........................................................290
For Pharmacology: A Patient-Centered Nursing Process Approach 12th Edition
By Linda E. Mccuistion Phd
Questions And Answers GRADED
A+
,TABLE OF CONTENTS
CHAPTER 01: DRUG DEVELOPMENT AND ETHICAL CONSIDERATIONS..................................................4
CHAPTER 02: PHARMACOKINETICS, PHARMACODYNAMICS, ANDPHARMACOGENETICS ................ 11
CHAPTER 03: CULTURAL CONSIDERATIONS ..................................................................................... 18
CHAPTER 04: COMPLEMENTARY AND ALTERNATIVE THERAPIES ....................................................... 21
CHAPTER 05: PEDIATRIC CONSIDERATIONS. ................................................................................... 26
CHAPTER 06: GERIATRIC CONSIDERATIONS ..................................................................................... 31
CHAPTER 07: DRUGS IN SUBSTANCE USE DISORDER ........................................................................36
CHAPTER 08: THE NURSING PROCESS AND PATIENT-CENTERED CARE ............................................... 45
CHAPTER 09: SAFETY AND QUALITY ................................................................................................. 49
CHAPTER 10: DRUG ADMINISTRATION ............................................................................................. 54
CHAPTER 11: DRUG CALCULATIONS ................................................................................................ 58
CHAPTER 12: FLUID VOLUME AND ELECTROLYTES............................................................................ 63
CHAPTER 13: VITAMIN AND MINERAL REPLACEMENT........................................................................ 70
CHAPTER 14: NUTRITIONAL SUPPORT ............................................................................................. 76
CHAPTER 15: ADRENERGIC AGONISTS AND ANTAGONISTS ..............................................................83
CHAPTER 16: CHOLINERGIC AGONISTS AND ANTAGONISTS ............................................................. 89
CHAPTER 17: STIMULANTS .............................................................................................................. 94
CHAPTER 18: DEPRESSANTS ........................................................................................................... 98
CHAPTER 19: ANTISEIZURE DRUGS ................................................................................................103
CHAPTER 20: DRUGS FOR PARKINSONISM AND ALZHEIMER'S DISEASE ......................................... 109
CHAPTER 21: DRUGS FOR NEUROMUSCULAR DISORDERS AND MUSCLESPASMS ........................... 114
CHAPTER 22: ANTIPSYCHOTICS AND ANXIOLYTICS ........................................................................ 120
,CHAPTER 23: ANTIDEPRESSANTS AND MOOD STABILIZERS........................................................... 126
CHAPTER 24: ANTIINFLAMMATORIES ............................................................................................ 132
CHAPTER 25: ANALGESICS ............................................................................................................ 144
CHAPTER 26: ANTIBACTERIALS .......................................................................................................150
CHAPTER 27: ANTITUBERCULARS, ANTIFUNGALS, AND ANTIVIRALS ................................................159
CHAPTER 28: PEPTIDES, ANTIMALARIALS, AND ANTHELMINTICS .................................................... 165
CHAPTER 29: HIV- AND AIDS-RELATED DRUGS ............................................................................... 175
CHAPTER 30: TRANSPLANT DRUGS ................................................................................................ 179
CHAPTER 31: VACCINES ................................................................................................................ 182
CHAPTER 32: ANTICANCER DRUGS................................................................................................ 186
CHAPTER 33: TARGETED THERAPIES TO TREAT CANCER.................................................................... 190
CHAPTER 34: BIOLOGIC RESPONSE MODIFIERS .............................................................................. 192
CHAPTER 35: UPPER RESPIRATORY DISORDERS .............................................................................. 196
CHAPTER 36: LOWER RESPIRATORY DISORDERS.............................................................................. 200
CHAPTER 37: CARDIAC GLYCOSIDES, ANTIANGINALS, ANDANTIDYSRHYTHMICS ............................ 204
CHAPTER 38: DIURETICS ................................................................................................................211
CHAPTER 39: ANTIHYPERTENSIVES................................................................................................ 214
CHAPTER 40: ANTICOAGULANTS, ANTIPLATELETS, AND THROMBOLYTICS ....................................... 220
CHAPTER 41: ANTIHYPERLIPIDEMICS AND PERIPHERAL VASODILATORS ......................................... 225
CHAPTER 42: GASTROINTESTINAL TRACT DISORDERS .................................................................... 229
CHAPTER 43: ANTIULCER DRUGS .................................................................................................. 240
CHAPTER 44: EYE AND EAR DISORDERS ......................................................................................... 245
CHAPTER 45: DERMATOLOGIC DISORDERS .................................................................................... 248
CHAPTER 46: PITUITARY, THYROID, PARATHYROID, AND ADRENALDISORDERS ................................ 252
CHAPTER 47: ANTIDIABETICS......................................................................................................... 258
CHAPTER 48: URINARY DISORDERS ................................................................................................264
CHAPTER 49: PREGNANCY AND PRETERM LABOR........................................................................... 268
CHAPTER 50: LABOR, DELIVERY, AND POSTPARTUM ....................................................................... 273
CHAPTER 51: NEONATAL AND NEWBORN ...................................................................................... 276
, CHAPTER 52: WOMEN'S REPRODUCTIVE HEALTH ............................................................................280
CHAPTER 53: MEN'S REPRODUCTIVE HEALTH................................................................................. 283
CHAPTER 54: SEXUALLY TRANSMITTED INFECTIONS....................................................................... 286
CHAPTER 55: ADULT AND PEDIATRIC EMERGENCY DRUGS. ...........................................................290
